• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Cipro I.V. (ciprofloxacin) For Intravenous Infusion

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

Summary View

Sections Modified


  • Photosensitivity/Phototoxicity
    • Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions...
  • Information for Patients
    • Patients should be advised: that photosensitivity/phototoxicity has been reported in patients receiving quinolones...


  • Skin/Hypersensitivity
    • Photosensitivity/Phototoxicity Reaction
  • Postmarketing Adverse Events
    • Photosensitivity/Phototoxicity Reaction